| Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy GK Siberry, DL Jacobson, HJ Kalkwarf, JW Wu, LA DiMeglio, R Yogev, ... Clinical infectious diseases 61 (6), 996-1003, 2015 | 156 | 2015 |
| Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV N Mulligan, BM Best, J Wang, EV Capparelli, A Stek, E Barr, SL Buschur, ... Aids 32 (6), 729-737, 2018 | 97 | 2018 |
| Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV JD Momper, BM Best, J Wang, EV Capparelli, A Stek, E Barr, ML Badell, ... Aids 32 (17), 2507-2516, 2018 | 71 | 2018 |
| Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1–infected children aged 2 through 18 years S Nachman, N Zheng, EP Acosta, H Teppler, B Homony, B Graham, ... Clinical infectious diseases 58 (3), 413-422, 2014 | 65 | 2014 |
| Nevirapine-versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial L Barlow-Mosha, K Angelidou, J Lindsey, M Archary, M Cotton, S Dittmer, ... Clinical Infectious Diseases 63 (8), 1113-1121, 2016 | 63 | 2016 |
| Live-attenuated respiratory syncytial virus vaccine candidate with deletion of RNA synthesis regulatory protein M2-2 is highly immunogenic in children EJ McFarland, RA Karron, P Muresan, CK Cunningham, ME Valentine, ... The Journal of infectious diseases 217 (9), 1347-1355, 2018 | 58 | 2018 |
| Effect of pregnancy on emtricitabine pharmacokinetics AM Stek, BM Best, W Luo, E Capparelli, S Burchett, C Hu, H Li, JS Read, ... HIV medicine 13 (4), 226-235, 2012 | 52 | 2012 |
| Live respiratory syncytial virus (RSV) vaccine candidate containing stabilized temperature-sensitivity mutations is highly attenuated in RSV-seronegative infants and children UJ Buchholz, CK Cunningham, P Muresan, D Gnanashanmugam, P Sato, ... The Journal of infectious diseases 217 (9), 1338-1346, 2018 | 50 | 2018 |
| Human immunodeficiency virus type 1 DNA decay dynamics with early, long-term virologic control of perinatal infection P Uprety, K Patel, B Karalius, C Ziemniak, YH Chen, SS Brummel, ... Clinical infectious diseases 64 (11), 1471-1478, 2017 | 47 | 2017 |
| Birth outcomes for pregnant women with HIV using tenofovir–Emtricitabine K Rough, GR Seage III, PL Williams, S Hernandez-Diaz, Y Huo, ... New England Journal of Medicine 378 (17), 1593-1603, 2018 | 45 | 2018 |
| Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with small hydrophobic noncoding region is highly immunogenic in children EJ McFarland, RA Karron, P Muresan, CK Cunningham, C Perlowski, ... The Journal of infectious diseases 221 (12), 2050-2059, 2020 | 41 | 2020 |
| Safety, tolerability, and pharmacokinetics of the broadly neutralizing human immunodeficiency virus (HIV)-1 monoclonal antibody VRC01 in HIV-exposed newborn infants CK Cunningham, EJ McFarland, RL Morrison, EV Capparelli, JT Safrit, ... The Journal of Infectious Diseases 222 (4), 628-636, 2020 | 36 | 2020 |
| Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study K Tassiopoulos, K Patel, J Alperen, D Kacanek, A Ellis, C Berman, ... BMJ open 6 (6), e011396, 2016 | 34 | 2016 |
| Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children EJ McFarland, RA Karron, P Muresan, CK Cunningham, J Libous, ... The Journal of infectious diseases 221 (4), 534-543, 2020 | 33 | 2020 |
| Dolutegravir pharmacokinetics in HIV-infected pregnant and postpartum women N Mulligan, BM Best, E Capparelli, A Stek, E Barr, E Smith, N Chakhtoura, ... Conference on Retroviruses and Opportunistic Infections, 22-25, 2016 | 30 | 2016 |
| Health outcomes of international HIV-infected adoptees in the US ER Wolf, S Beste, E Barr, J Wallace, EJ McFarland, MJ Abzug, J Darrow, ... The Pediatric Infectious Disease Journal 35 (4), 422-427, 2016 | 28 | 2016 |
| Safety and tolerability of antiretrovirals during pregnancy A Weinberg, J Forster-Harwood, J Davies, EJ McFarland, J Pappas, ... Infectious diseases in obstetrics and gynecology 2011 (1), 867674, 2011 | 24 | 2011 |
| Evaluation of recombinant live-attenuated respiratory syncytial virus (RSV) vaccines RSV/ΔNS2/Δ1313/I1314l and RSV/276 in RSV-seronegative children CK Cunningham, RA Karron, P Muresan, MS Kelly, EJ McFarland, ... The Journal of Infectious Diseases 226 (12), 2069-2078, 2022 | 21 | 2022 |
| Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV KM Brooks, JD Momper, M Pinilla, AM Stek, E Barr, A Weinberg, ... Aids 35 (3), 407-417, 2021 | 21 | 2021 |
| Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review C Smith, JE Forster, MJ Levin, J Davies, J Pappas, K Kinzie, E Barr, ... PLoS One 10 (5), e0127062, 2015 | 21 | 2015 |
Coleen K CunninghamUniversity of California, IrvineVerified email at uci.edu